However, despite the undoubtfully important role of ADAM17 in tumour disease (Arribas et al, 2006; Ringel et al, 2006), our results cannot prove ADAM17 to be a prognostic marker in pancreatic cancer. This evidence concerns the gene ADAM17 and familial pancreatic carcinoma.